Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cryptic Afflictions LLC was a biotechnology company focused on the discovery and characterization of "Cryptovirus," a novel RNA virus within the Rubulavirus genus. Led by virologist Dr. Steven J. Robbins, the company investigated the link between this virus and various neurological and neuropsychiatric disorders, including Multiple Sclerosis, Chronic Fatigue Syndrome, and Epilepsy. Their work involved developing diagnostic tests to detect virus-specific antibodies and exploring potential antiviral therapies. The company's research was notably supported by the National CFIDS Foundation and eventually led to a merger with Global Medical Technologies to form Limina Biotechnologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cryptic Afflictions.